The Europe Clinical Trials Matching Software Market would witness market growth of 13.2% CAGR during the forecast period (2023-2030).
Patient recruitment and matching in clinical trials can be time-consuming, and finding a suitable match can be challenging. While recruiting patients, screening or locating qualified potential participants, considering all aspects of the trials, confirming awareness, and obtaining informed consent are all considered. Importantly, individuals must be enrolled following the eligibility requirements; therefore, the trial matching technology has proven useful, particularly in the COVID-19 scenario. The software not only aids in finding the ideal match but also reduces R&D expenses, allowing for more efficient operations without human intervention. The software vendors are implementing innovative techniques to strengthen their market position.
The digitization of research paves the way for expanding the market. Pharmaceutical companies, biotechnology firms, clinical research organizations, and manufacturers of medical devices regularly conduct clinical trials to assess the safety and efficacy of new medications, diagnostics, and treatments. The market expansion is likely fuelled by the increasing cases of chronic diseases and the increasing demand for clinical trials. In addition, the digitization of research facilitates the development of new markets. Utilizing cutting-edge technologies such as EDC and clinical trial management systems, market participants can keep track of patient data and reduce expenses associated with monitoring.
The market in Europe has been experiencing steady growth over the years, driven by several factors contributing to adopting these solutions in the region. Europe boasts a well-developed and advanced healthcare infrastructure, including world-class research institutions, hospitals, and clinical trial sites. This infrastructure supports conducting a wide range of clinical trials, driving the demand for CTMS solutions. Europe is a hub for clinical research, with a high volume of clinical trials across various therapeutic areas. The growing number of trials necessitates efficient trial management tools, leading to the adoption of CTMS solutions.
The Germany market dominated the Europe Clinical Trials Matching Software Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $21,159.5 Thousands by 2030. The UK market is exhibiting a CAGR of 12.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 14.1% during (2023 - 2030).
Based on Deployment Mode, the market is segmented into Web & Cloud-based, and On-premises. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, CROs, and Medical Device Firms. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Clinical Trials Matching Software Market will Hit $362.7 Million by 2030, at a CAGR of 13.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Clario, IBM Corporation, Antidote Technologies, Inc., Ofni Systems Inc., Advarra, Inc., ArisGlobal LLC (Nordic Capital Limited), Teckro, Inc., BSI Business Systems Integration AG, Clinical Trials Mobile Application, Optimapharm d.o.o.
Scope of the Study
Market Segments Covered in the Report:
By Deployment Mode
- Web & Cloud-based
- On-premises
By End-use
- Pharmaceutical & Biotechnology Companies
- CROs
- Medical Device Firms
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Clario
- IBM Corporation
- Antidote Technologies, Inc.
- Ofni Systems Inc.
- Advarra, Inc.
- ArisGlobal LLC (Nordic Capital Limited)
- Teckro, Inc.
- BSI Business Systems Integration AG
- Clinical Trials Mobile Application
- Optimapharm d.o.o.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Clinical Trials Matching Software Market, by Deployment Mode
1.4.2 Europe Clinical Trials Matching Software Market, by End-use
1.4.3 Europe Clinical Trials Matching Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.1 Porter’s Five Force Analysis
Chapter 4. Europe Clinical Trials Matching Software Market, by Deployment Mode
4.1 Europe Web & Cloud-based Market, by Country
4.2 Europe On-premises Market, by Country
Chapter 5. Europe Clinical Trials Matching Software Market, by End-use
5.1 Europe Pharmaceutical & Biotechnology Companies Market, by Country
5.2 Europe CROs Market, by Country
5.3 Europe Medical Device Firms Market, by Country
Chapter 6. Europe Clinical Trials Matching Software Market, by Country
6.1 Germany Clinical Trials Matching Software Market
6.1.1 Germany Clinical Trials Matching Software Market, by Deployment Mode
6.1.2 Germany Clinical Trials Matching Software Market, by End-use
6.2 UK Clinical Trials Matching Software Market
6.2.1 UK Clinical Trials Matching Software Market, by Deployment Mode
6.2.2 UK Clinical Trials Matching Software Market, by End-use
6.3 France Clinical Trials Matching Software Market
6.3.1 France Clinical Trials Matching Software Market, by Deployment Mode
6.3.2 France Clinical Trials Matching Software Market, by End-use
6.4 Russia Clinical Trials Matching Software Market
6.4.1 Russia Clinical Trials Matching Software Market, by Deployment Mode
6.4.2 Russia Clinical Trials Matching Software Market, by End-use
6.5 Spain Clinical Trials Matching Software Market
6.5.1 Spain Clinical Trials Matching Software Market, by Deployment Mode
6.5.2 Spain Clinical Trials Matching Software Market, by End-use
6.6 Italy Clinical Trials Matching Software Market
6.6.1 Italy Clinical Trials Matching Software Market, by Deployment Mode
6.6.2 Italy Clinical Trials Matching Software Market, by End-use
6.7 Rest of Europe Clinical Trials Matching Software Market
6.7.1 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode
6.7.2 Rest of Europe Clinical Trials Matching Software Market, by End-use
Chapter 7. Company Profiles
7.1 Clario
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Partnerships, Collaborations, and Agreements:
7.1.3 SWOT Analysis
7.2 IBM Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Antidote Technologies, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Ofni Systems Inc.
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Advarra, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 ArisGlobal LLC (Nordic Capital Limited)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Geographical Expansions:
7.6.3 SWOT Analysis
7.7 Teckro, Inc.
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 BSI Business Systems Integration AG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Clinical Trials Mobile Application
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Optimapharm d.o.o.
7.10.1 Company Overview
7.10.2 SWOT Analysis
TABLE 1 Europe Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 2 Europe Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 3 Europe Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 4 Europe Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 5 Europe Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
TABLE 6 Europe Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
TABLE 7 Europe On-premises Market, by Country, 2019 - 2022, USD Thousands
TABLE 8 Europe On-premises Market, by Country, 2023 - 2030, USD Thousands
TABLE 9 Europe Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 10 Europe Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 11 Europe Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
TABLE 12 Europe Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
TABLE 13 Europe CROs Market, by Country, 2019 - 2022, USD Thousands
TABLE 14 Europe CROs Market, by Country, 2023 - 2030, USD Thousands
TABLE 15 Europe Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
TABLE 16 Europe Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
TABLE 17 Europe Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
TABLE 18 Europe Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
TABLE 19 Germany Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 20 Germany Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 21 Germany Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 22 Germany Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 23 Germany Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 24 Germany Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 25 UK Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 26 UK Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 27 UK Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 28 UK Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 29 UK Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 30 UK Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 31 France Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 32 France Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 33 France Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 34 France Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 35 France Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 36 France Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 37 Russia Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 38 Russia Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 39 Russia Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 40 Russia Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 41 Russia Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 42 Russia Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 43 Spain Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 44 Spain Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 45 Spain Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 46 Spain Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 47 Spain Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 48 Spain Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 49 Italy Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 50 Italy Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 51 Italy Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 52 Italy Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 53 Italy Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 54 Italy Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 55 Rest of Europe Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 56 Rest of Europe Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 57 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 58 Rest of Europe Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 59 Rest of Europe Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 60 Rest of Europe Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 61 Key Information – Clario
TABLE 62 Key Information – IBM Corporation
TABLE 63 Key Information – Antidote Technologies, Inc.
TABLE 64 Key Information – Ofni Systems Inc.
TABLE 65 Key Information – Advarra, Inc.
TABLE 66 Key Information – ArisGlobal LLC
TABLE 67 Key Information – Teckro, Inc.
TABLE 68 Key Information – BSI Business Systems Integration AG
TABLE 69 Key Information – Clinical Trials Mobile Application
TABLE 70 Key Information – Optimapharm d.o.o.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Clinical Trials Matching Software Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Clinical Trials Matching Software Market
FIG 4 Porter’s Five Force Analysis: Clinical Trials Matching Software Market
FIG 5 Europe Clinical Trials Matching Software Market share, by Deployment Mode, 2022
FIG 6 Europe Clinical Trials Matching Software Market share, by Deployment Mode, 2030
FIG 7 EUROPE CLINICAL TRIALS MATCHING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2019 - 2030, USD THOUSANDS
FIG 8 Europe Clinical Trials Matching Software Market share, by End-use, 2022
FIG 9 Europe Clinical Trials Matching Software Market share, by End-use, 2030
FIG 10 EUROPE CLINICAL TRIALS MATCHING SOFTWARE MARKET, BY END-USE, 2019 - 2030, USD THOUSANDS
FIG 11 Europe Clinical Trials Matching Software Market share, by Country, 2022
FIG 12 Europe Clinical Trials Matching Software Market share, by Country, 2030
FIG 13 EUROPE CLINICAL TRIALS MATCHING SOFTWARE MARKET, BY COUNTRY, 2019 - 2030, USD THOUSANDS
FIG 14 SWOT Analysis: Clario
FIG 15 SWOT Analysis: IBM Corporation
FIG 16 SWOT Analysis: Antidote Technologies, Inc.
FIG 17 SWOT Analysis: Ofni Systems Inc.
FIG 18 SWOT Analysis: Advarra, Inc.
FIG 19 SWOT Analysis: ArisGlobal LLC
FIG 20 SWOT Analysis: Teckro, Inc.
FIG 21 SWOT Analysis: BSI Business Systems Integration AG
FIG 22 SWOT Analysis: Clinical Trials Mobile Application
FIG 23 SWOT Analysis: Optimapharm d.o.o.